Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

Detalles Bibliográficos
Autores principales: Tecza, Karolina, Pamula-Pilat, Jolanta, Kolosza, Zofia, Radlak, Natalia, Grzybowska, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565546/
http://dx.doi.org/10.1186/1897-4287-13-S1-A4
_version_ 1782389586697125888
author Tecza, Karolina
Pamula-Pilat, Jolanta
Kolosza, Zofia
Radlak, Natalia
Grzybowska, Ewa
author_facet Tecza, Karolina
Pamula-Pilat, Jolanta
Kolosza, Zofia
Radlak, Natalia
Grzybowska, Ewa
author_sort Tecza, Karolina
collection PubMed
description
format Online
Article
Text
id pubmed-4565546
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45655462015-09-18 Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy Tecza, Karolina Pamula-Pilat, Jolanta Kolosza, Zofia Radlak, Natalia Grzybowska, Ewa Hered Cancer Clin Pract Meeting Abstract BioMed Central 2015-09-09 /pmc/articles/PMC4565546/ http://dx.doi.org/10.1186/1897-4287-13-S1-A4 Text en Copyright © 2015 Tecza et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Tecza, Karolina
Pamula-Pilat, Jolanta
Kolosza, Zofia
Radlak, Natalia
Grzybowska, Ewa
Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title_full Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title_fullStr Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title_full_unstemmed Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title_short Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
title_sort genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565546/
http://dx.doi.org/10.1186/1897-4287-13-S1-A4
work_keys_str_mv AT teczakarolina geneticpolymorphismsandovariancancerriskandresponsetopaclitaxelcisplatinchemotherapy
AT pamulapilatjolanta geneticpolymorphismsandovariancancerriskandresponsetopaclitaxelcisplatinchemotherapy
AT koloszazofia geneticpolymorphismsandovariancancerriskandresponsetopaclitaxelcisplatinchemotherapy
AT radlaknatalia geneticpolymorphismsandovariancancerriskandresponsetopaclitaxelcisplatinchemotherapy
AT grzybowskaewa geneticpolymorphismsandovariancancerriskandresponsetopaclitaxelcisplatinchemotherapy

Ejemplares similares